Blueprint Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Blueprint Investment Partners's AMGN Position: Q1 2025 in Review
Blueprint Investment Partners sold out of Amgen (AMGN) in Q1 2025, closing a stake of 899 shares — an estimated $234K sold.
Blueprint Investment Partners first reported a position in AMGN in Q1 2021 and held it in 12 quarters. The position peaked at $1.4M in Q4 2022. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.
- Blueprint Investment Partners reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
- Blueprint Investment Partners sold 899 Amgen shares in Q1 2025, an estimated $234K.
- Blueprint Investment Partners first reported a position in Amgen in Q1 2021 and held it in 12 quarters.
- Blueprint Investment Partners's Amgen position peaked at $1.4M in Q4 2022.
- 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.
Based on Blueprint Investment Partners's 13F filing for Q1 2025, filed 12 May 2025.